Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-24-114786

Chief Executive Officer sold 4,293 shares at $46.28 ($198,680)

  • Chief Executive Officer acquired 8,333 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Kulkarni Samarth Chief Executive Officer 2024-10-13 Option exercise +8,333 230,833 D
Kulkarni Samarth Chief Executive Officer 2024-10-14 Sale −4,293 $46.28 $198,680 226,540 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2024-10-13 Option exercise · Restricted Stock Units −8,333 16,667 D
Open-market sales · 4,293 sh · avg $46.28 · $198,680
Loading xslF345X05/ownership.xml…